Patient retrospective evaluation of change: An appropriate outcome measure for clinical trials?

被引：0
|
作者：
Fischer, D [1 ]
Stewart, AL [1 ]
Bloch, DA [1 ]
Lorig, K [1 ]
Laurent, D [1 ]
Holman, HR [1 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1177
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [41] Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
    Gaffney, R. G.
    Feng, R.
    Pearson, D.
    Tarazi, M.
    Werth, V. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S97 - S97
  • [42] Examining Cutaneous Disease Activity As an Outcome Measure for Clinical Trials in Dermatomyositis
    Gaffney, Rebecca
    Tarazi, Meera
    Feng, Rui
    Pearson, David
    Werth, Victoria P.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [43] The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials
    Bermel, Robert A.
    Fisher, Elizabeth
    Cohen, Jeffrey A.
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (04) : 687 - 701
  • [44] Dystrophin as a biochemical outcome measure in Duchenne muscular dystrophy clinical trials
    Sardone, V.
    Ellis, M.
    Torelli, S.
    Feng, L.
    Chambers, D.
    Ricotti, V.
    Domingos, J. Pisco
    Phadke, R.
    Sewry, C. A.
    Morgan, J.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S16 - S16
  • [45] Evaluation of patient information sheets in clinical trials
    Frimas, V
    Chedru-Legros, V
    THERAPIE, 2002, 57 (06): : 518 - 523
  • [46] Reporting of patient reported outcome (PRO) in clinical trials:A systematic review of clinical trials.
    Vidal-Fisher, Liat
    Boixader, Laura Vidal
    Andrianov, Vasily
    Curtis, Kelly Kevelin
    Shepshelovich, Daniel
    Moss, Keren Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
    Spuls, P. I.
    Gerbens, L. A. A.
    Simpson, E.
    Apfelbacher, C. J.
    Chalmers, J. R.
    Thomas, K. S.
    Prinsen, C. A. C.
    von Kobyletzki, L. B.
    Singh, J. A.
    Williams, H. C.
    Schmitt, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (04) : 979 - 984
  • [48] Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care A Review
    Thomas, Merrill
    Jones, Philip G.
    Arnold, Suzanne V.
    Spertus, John A.
    JAMA CARDIOLOGY, 2021, 6 (05) : 593 - 599
  • [49] A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials
    Raspa, Melissa
    Bann, Carla M.
    Gwaltney, Angela
    Benke, Timothy A.
    Fu, Cary
    Glaze, Daniel G.
    Haas, Richard
    Heydemann, Peter
    Jones, Mary
    Kaufmann, Walter E.
    Lieberman, David
    Marsh, Eric
    Peters, Sarika
    Ryther, Robin
    Standridge, Shannon
    Skinner, Steven A.
    Percy, Alan K.
    Neul, Jeffrey L.
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2020, 125 (06): : 493 - 509
  • [50] DEVELOPMENT AND VALIDATION OF A PATIENT CENTERED OUTCOME MEASURE FOR USE IN DEMENTIA DRUG TRIALS
    Rockwood, K.
    Stanley, J.
    Dunn, T.
    Howlett, S. E.
    VALUE IN HEALTH, 2019, 22 : S183 - S183
12345